newsfilter
← Latest News
GlobeNewswire·

Metagenomi Reports Business Updates and First Quarter 2025 Financial Results

- Nonhuman primate (NHP) study in hemophilia A demonstrated therapeutically relevant factor VIII (FVIII) activity with durable response through approximately 19 months with an encouraging safety profile - Well